The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 5, 2025 | Kua Khai Loon | 10% Owner | Sell(S) | 19K | $7.01 | $134K |
| Sep 4, 2025 | Ong Yee Lung | 10% Owner | Other(J) | 186K | — | — |
| Sep 4, 2025 | Ong Yee Lung | 10% Owner | Other(J) | 186K | — | $0 |
| Sep 4, 2025 | Yap Kim Choy | 10% Owner | Other(J) | 186K | — | — |
| Sep 4, 2025 | Yap Kim Choy | 10% Owner | Other(J) | 186K | — | $0 |
| Sep 4, 2025 | Kua Khai Loon | 10% Owner | Other(J) | 186K | — | — |
| Sep 4, 2025 | Kua Khai Loon | 10% Owner | Other(J) | 186K | — | $0 |
| Jul 30, 2025 | Lazar David E. | 10% Owner | Sell(S) | 7K | $12.36 | $83K |
| Feb 26, 2025 | Ben-Tzvi Avraham | Director | Grant(A) | 700K | — | $0 |
| Feb 26, 2025 | Lazar David E. | Interim CEO, 10% Owner | Sell(S) | 194.6M | $0.03 | $5.8M |
| Feb 26, 2025 | Lazar David E. | Interim CEO, 10% Owner | Option exercise(M) | 2.6M | — | — |
| Feb 26, 2025 | Lazar David E. | Interim CEO, 10% Owner | Option exercise(M) | 192.0M | — | — |
| Feb 26, 2025 | Lazar David E. | Interim CEO, 10% Owner | Option exercise(M) | 1.0M | — | — |
| Feb 26, 2025 | Lazar David E. | Interim CEO, 10% Owner | Option exercise(M) | 1.7M | — | — |
| Feb 26, 2025 | Natan David | Director | Grant(A) | 700K | — | $0 |
| Feb 6, 2025 | Lazar David E. | Interim CEO, 10% Owner | Grant(A) | 2.1M | — | — |
| Jan 2, 2025 | Natan David | Director | Grant(A) | 100K | — | — |
| Jan 29, 2024 | Schwartz Brian | Interim Chief Medical Officer, Director | Grant(A) | 13K | — | $0 |
| Jan 29, 2024 | Schwartz Brian | Interim Chief Medical Officer, Director | Grant(A) | 13K | — | $0 |
| Dec 21, 2023 | Rombotis Spiro George | President and CEO, Director | Buy(P) | 6K | $3.32 | $20K |
| Dec 21, 2023 | Rombotis Spiro George | President and CEO, Director | Buy(P) | 6K | — | $0 |
| Dec 21, 2023 | McBarron Paul | See Remarks, Director | Buy(P) | 2K | $3.32 | $6K |
| Dec 21, 2023 | McBarron Paul | See Remarks, Director | Buy(P) | 2K | — | $0 |
| Jun 30, 2023 | Schwartz Brian | Director | Grant(A) | 21K | — | $0 |
| Jun 30, 2023 | Schwartz Brian | Director | Grant(A) | 42K | — | $0 |
| Jun 30, 2023 | Henney Christopher S | Director | Grant(A) | 21K | — | $0 |
| Jun 30, 2023 | Henney Christopher S | Director | Grant(A) | 42K | — | $0 |
| Jun 30, 2023 | Ferguson Kenneth M. | Director | Grant(A) | 21K | — | $0 |
| Jun 30, 2023 | Ferguson Kenneth M. | Director | Grant(A) | 42K | — | $0 |
| Jun 30, 2023 | Walker Karin L | Director | Grant(A) | 21K | — | $0 |
| Jun 30, 2023 | Walker Karin L | Director | Grant(A) | 42K | — | $0 |
| Jun 30, 2023 | Kirschbaum Mark | Chief Medical Officer | Grant(A) | 70K | — | $0 |
| Jun 30, 2023 | McBarron Paul | See Remarks, Director | Grant(A) | 70K | — | $0 |
| Jun 30, 2023 | Spiegel Robert J. | Director | Grant(A) | 21K | — | $0 |
| Jun 30, 2023 | Spiegel Robert J. | Director | Grant(A) | 42K | — | $0 |
| Jun 30, 2023 | Barker Sam L | Director | Grant(A) | 21K | — | $0 |
| Jun 30, 2023 | Barker Sam L | Director | Grant(A) | 42K | — | $0 |
| Jun 30, 2023 | Rombotis Spiro George | President and CEO, Director | Grant(A) | 110K | — | $0 |
| Jan 31, 2023 | Kirschbaum Mark | Chief Medical Officer | Grant(A) | 31K | — | $0 |
| Jan 31, 2023 | Rombotis Spiro George | President and CEO, Director | Grant(A) | 58K | — | $0 |
| Jan 31, 2023 | McBarron Paul | See Remarks, Director | Grant(A) | 31K | — | $0 |
| Jun 14, 2022 | Barker Sam L | Director | Grant(A) | 16K | — | $0 |
| Jun 14, 2022 | Barker Sam L | Director | Grant(A) | 32K | — | $0 |
| Jun 14, 2022 | Henney Christopher S | Director | Grant(A) | 16K | — | $0 |
| Jun 14, 2022 | Henney Christopher S | Director | Grant(A) | 32K | — | $0 |
| Jun 14, 2022 | Schwartz Brian | Director | Grant(A) | 16K | — | $0 |
| Jun 14, 2022 | Schwartz Brian | Director | Grant(A) | 32K | — | $0 |
| Jun 14, 2022 | Sems Lloyd | Director | Grant(A) | 16K | — | $0 |
| Jun 14, 2022 | Sems Lloyd | Director | Grant(A) | 32K | — | $0 |
| Jun 14, 2022 | Spiegel Robert J. | Director | Grant(A) | 16K | — | $0 |
| Jun 14, 2022 | Spiegel Robert J. | Director | Grant(A) | 32K | — | $0 |
| Jun 14, 2022 | Walker Karin L | Director | Grant(A) | 16K | — | $0 |
| Jun 14, 2022 | Walker Karin L | Director | Grant(A) | 32K | — | $0 |
| Jun 14, 2022 | Ferguson Kenneth M. | Director | Grant(A) | 24K | — | $0 |
| Jun 14, 2022 | Ferguson Kenneth M. | Director | Grant(A) | 47K | — | $0 |
| Dec 13, 2021 | Rombotis Spiro George | President and CEO, Director | Grant(A) | 190K | — | $0 |
| Dec 13, 2021 | McBarron Paul | See Remarks, Director | Grant(A) | 100K | — | $0 |
| Dec 13, 2021 | Kirschbaum Mark | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Nov 30, 2021 | Barker Sam L | Director | Sell(S) | 12 | $3.57 | $43 |
| Nov 18, 2021 | Rombotis Spiro George | President and CEO, Director | Buy(P) | 4K | $4.50 | $18K |
| Aug 24, 2021 | Barker Sam L | Director | Buy(P) | 1K | $5.00 | $5K |
| Jun 15, 2021 | Hradsky Gregory T. | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Hradsky Gregory T. | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Barker Sam L | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Barker Sam L | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Spiegel Robert J. | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Spiegel Robert J. | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Sems Lloyd | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Sems Lloyd | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Henney Christopher S | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Henney Christopher S | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Walker Karin L | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Walker Karin L | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Walker Karin L | Director | Grant(A) | 1K | — | $0 |
| Jun 15, 2021 | Walker Karin L | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Schwartz Brian | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Schwartz Brian | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Schwartz Brian | Director | Grant(A) | 2K | — | $0 |
| Jun 15, 2021 | Schwartz Brian | Director | Grant(A) | 1K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).